Abiopharma

INSM Investors Have Opportunity to Join Insmed Incorporated Fraud Investigation with the Schall Law Firm

SOBRsafe Announces Closing of $2 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Reviva to Present at the Sachs 9th Annual Neuroscience Innovation Forum

Dynavax Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Dynavax Technologies Corporation - DVAX

Applied Digital to Spin Out Cloud Business, Proposes Business Combination with EKSO to Launch ChronoScale

ResMed Inc. Daily Stock Update

Proposed issue of securities - MSB

Mesoblast Enters into Non-Dilutive Lower Cost 5-Year Credit

Notification from BriaCell Therapeutics Corp.

Royalty Pharma Acquires Remaining Royalty Interest in Roche’s Evrysdi for $240 Million and Potential Milestones